Literature DB >> 29113271

Significance of imaging and clinical features in the differentiation between primary and secondary pulmonary lymphoma.

Yuhao Dong1,2, Miaoyu Zeng3, Bin Zhang1,3, Lujun Han4, Entao Liu5, Zhouyang Lian1,3, Jing Liu1,3, Changhong Liang1, Shuixing Zhang1.   

Abstract

The aim of the present study was to analyze the differences in imaging and clinical features between primary pulmonary lymphoma (PPL) and secondary pulmonary lymphoma (SPL) to provide insight into pulmonary lymphoma for an improved clinical diagnosis. A retrospective study of 38 patients with pulmonary lymphoma (19 PPL and 19 SPL) treated between September 1, 2006, and December 31, 2015, was performed. The clinical manifestations, and computed tomography (CT) and positron emission tomography-CT images of each case were collected. χ2 and Fisher's exact tests were applied to assess statistically significant differences between PPL and SPL in terms of clinical and imaging features. The significant variables were further applied to canonical discriminate analysis. The CT results revealed that the occurrence of a >3-cm mass (P=0.007), peripheral location (lower than the segmental bronchi) (P=0.027), cavitation (P=0.008) and consolidation (P=0.027) were associated with PPL, while peripheral and hilar location (P=0.003) or mediastinal and hilar lymph node engagement (P=0.044) were predominantly observed in SPL. However, no significant differences between clinical manifestations and the maximum standard uptake value of pulmonary lesions in PPL and SPL were identified (all P>0.05). A function derived from discriminate analysis was generated that may predict the affiliation to PPL or SPL radiographically, with an overall accuracy of ≤92.1%. The results of the present study revealed that PPL and SPL exhibit distinctive features on CT images due to distinct molecular mechanisms and growth patterns. Careful observation of CT features may be useful in the diagnosis of PPL and SPL regarding the tumor morphology, location and lymph node involvement.

Entities:  

Keywords:  clinical features; computed tomography; diagnosis; discriminate analysis; primary pulmonary lymphoma; secondary pulmonary lymphoma

Year:  2017        PMID: 29113271      PMCID: PMC5661413          DOI: 10.3892/ol.2017.6962

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

Review 1.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Authors:  B D Cheson; S J Horning; B Coiffier; M A Shipp; R I Fisher; J M Connors; T A Lister; J Vose; A Grillo-López; A Hagenbeek; F Cabanillas; D Klippensten; W Hiddemann; R Castellino; N L Harris; J O Armitage; W Carter; R Hoppe; G P Canellos
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

2.  Detection of MALT1 gene rearrangements in BAL fluid cells for the diagnosis of pulmonary mucosa-associated lymphoid tissue lymphoma.

Authors:  Takashi Kido; Kazuhiro Yatera; Shingo Noguchi; Yasumasa Sakurai; Shuya Nagata; Minako Kozaki; Susumu Tokuyama; Takaaki Ogoshi; Toshinori Kawanami; Chiharu Yoshii; Hiroshi Mukae
Journal:  Chest       Date:  2011-07-14       Impact factor: 9.410

3.  [A clinical analysis of 40 cases of primary and secondary pulmonary lymphoma].

Authors:  Xiaoting Niu; Hong Hu; Jie Gao; Yongkang Nie; Wei Zhao; Hanyi Xu; Xue Bai; Liangan Chen
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2014-07

Review 4.  Forty years literature review of primary lung lymphoma.

Authors:  Haralabos Parissis
Journal:  J Cardiothorac Surg       Date:  2011-03-03       Impact factor: 1.637

5.  Clonality analysis of alveolar B lymphocytes contributes to the diagnostic strategy in clinical suspicion of pulmonary lymphoma.

Authors:  Simona Zompi; Louis-Jean Couderc; Jacques Cadranel; Martine Antoine; Bernard Epardeau; Jocelyne Fleury-Feith; Natalia Popa; François Santoli; Jean-Pierre Farcet; Marie-Hélène Delfau-Larue
Journal:  Blood       Date:  2004-01-08       Impact factor: 22.113

6.  Rare pulmonary neoplasms.

Authors:  D L Miller; M S Allen
Journal:  Mayo Clin Proc       Date:  1993-05       Impact factor: 7.616

Review 7.  Primary pulmonary lymphoma.

Authors:  J Cadranel; M Wislez; M Antoine
Journal:  Eur Respir J       Date:  2002-09       Impact factor: 16.671

8.  18F-FDG PET/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstruction.

Authors:  Eugene J Teoh; Daniel R McGowan; Kevin M Bradley; Elizabeth Belcher; Edward Black; Alastair Moore; Annemarie Sykes; Fergus V Gleeson
Journal:  Eur Radiol       Date:  2016-02-25       Impact factor: 5.315

9.  Primary pulmonary lymphoma: About five cases and literature review.

Authors:  Noura Majid; El Bakraoui Kamal; Boukir Oncology; Aassab Rachid; Inrhaoun Hannane Errihani Hassan
Journal:  Lung India       Date:  2014-01

10.  Primary Pulmonary Diffuse Large B-Cell Lymphoma on FDG PET/CT-MRI and DWI.

Authors:  Huiting Xu; Kai Xu; Ru Wang; Xiaohua Liu
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.817

View more
  4 in total

1.  Diagnostic and prognostic factors for patients with primary pulmonary non-Hodgkin's lymphoma: A 16-year single-center retrospective study.

Authors:  Jiang Qian; Dong-Lan Luo; Jin-E Zhang; Wen-Yu Li; Xing-Lin Gao; Xiang-Feng Fang; Hong An; Jun-Liang Deng; Qiong Li; Jian Wu
Journal:  Oncol Lett       Date:  2019-06-12       Impact factor: 2.967

2.  The characteristic computed tomography findings of pulmonary B-cell non-Hodgkin's lymphoma and their role in predicting patient survival.

Authors:  Yan Wang; Zhao-Cheng Pan; Lan Zhu; Yuan-Yuan Ma; Mu-Chen Zhang; Li Wang; Wei-Li Zhao; Fu-Hua Yan; Qi Song
Journal:  Quant Imaging Med Surg       Date:  2021-02

3.  Primary Pulmonary Diffuse Large B Cell Lymphoma Mimicking Metastasis: A Case Report and Literature Review.

Authors:  Bailong Liu; Hui Liu; Liang Guo; Yunfei Ma; Meng Guan; Min Liu
Journal:  Onco Targets Ther       Date:  2020-06-19       Impact factor: 4.147

4.  Role of 18F-FDG PET/CT in patients affected by pulmonary primary lymphoma.

Authors:  Ying Peng; Wanling Qi; Zhehuang Luo; Qingyun Zeng; Yujuan Huang; Yulu Wang; Amit Sharma; Ingo G H Schmidt-Wolf; Fengxiang Liao
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.